NASHVILLE, Tenn., Sept. 24, 2018 /PRNewswire/ -- KEPRO announced today the appointment of Michael Ansel as chief growth officer to bolster KEPRO's solution delivery, cultivate client relationships and develop sales strategies for revenue and market share growth.
With more than 30 years of business development and client management experience, Mr. Ansel will be leading KEPRO's business development in existing and new markets focused on clinical outcomes, quality improvement, and cost-containment solutions.
"Michael will be invaluable to defining and accelerating KEPRO's growth plans," said KEPRO CEO Joel Portice. "With our focus on growth and evolution as a leading healthcare service provider, Michael's knowledge and strategic approach to organizational plans, integrations, alliances and new business partnerships will be instrumental in KEPRO's growth portfolio over the coming years."
Mr. Ansel will be responsible for KEPRO's long-term strategy to transform KEPRO's solution delivery in the private, public and federal markets. Leveraging his experience, Mr. Ansel will enhance KEPRO's current constituent relationships, manage and grow business opportunities through new sales, expand existing relationships and execute seamless solution integration through mergers and acquisitions.
"KEPRO is well known for their service offerings and client relationships," said Chief Growth Officer Michael Ansel. "I am excited to be part of the team to assist the organization in furthering its position in the healthcare marketplace through strategic partnerships, enhanced outcomes and improved services."
Prior to joining KEPRO, Mr. Ansel was the Chief Growth Officer for Matrix Medical Network, a care management and assessment services company, where he led the company's account management, business development and sales functions. Under his leadership, Matrix experienced significant existing client growth, entered new markets, added a large number of new logo clients and completed two acquisitions.
Before his time at Matrix Medical Network, Mr. Ansel was the Executive Vice President of Business Development for BioIQ, Inc., a population health technology company. In addition, Mr. Ansel led corporate development at ScriptSave and PharmMD Solutions LLC. He has also held various executive leadership positions managing growth, corporate development and sales.
"His experience as a leader in defining strategic approaches to performance enhancement and operational efficiencies will allow us to further improve our services to build upon our current expertise and target additional healthcare solution markets," said Portice.
Mr. Ansel will focus on not only the growth of existing KEPRO clients, but also building and deploying the strategies to enter new markets for the organization.
To learn more about the services and solutions KEPRO offers, visit www.kepro.com.
Media Contact: Jamie Kopko, Director of Corporate Communications, JKopko@Kepro.com, 717.564.8288 x7076